TGA hides from questions about sudden infant deaths after vaccination
TGA hides from questions about sudden infant deaths after vaccination
A string of sudden unexpected deaths in infants following the Infanrix Hexa® vaccine has forced the drug regulator to go to ground.
Sudden unexpected death in infancy (SUDI) and sudden infant death syndrome (SIDS) are names for the sudden and unexpected death of a baby when there is no apparent cause of death.
The Therapeutic Goods Administration (TGA) has gone to ground after being confronted with questions about a series of sudden deaths in infants who received the Infanrix-Hexa® vaccine.
The “hexavalent” vaccine protects against six diseases (diphtheria, tetanus, whooping cough, polio, hepatitis B and Hib) and is administered to infants at 2, 4 and 6 months of age.
Approved by the TGA in 2006, the vaccine lies at the heart of the National Immunisation Program, and has been administered to millions of babies across the country.
FOI request
A freedom of information (FOI) request for the number of deaths reported after use of the Infanrix-Hexa® vaccine has revealed some worrying data.